Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Semin Arthritis Rheum. 2019 Jul 11;50(1):54–58. doi: 10.1016/j.semarthrit.2019.07.002

Table 1:

Characteristics of Study Patients

Variable N = 153 patients
Age (years), mean (SD) 58.5 (11.4)
Male, n (%) 141 (92)
Race, n (%)
 White 99 (65)
 Non-white 54 (35)
Duration since gout diagnosis (years), mean (SD) 14.9 (10.3)
Total daily allopurinol dose, n (%)
 300mg 125 (82)
 >300mg 28 (18)
Duration of allopurinol treatment (years), mean (SD) 5.1 (6.9)
SU level, n (%)
 <6 mg/dL 78 (51)
 ≥6 mg/dL 75 (49)
Subcutaneous tophi, n (%) 48 (31)

SU = serum urate; SD = standard deviation